TriCor Data Close At Hand; Will It Strike ACCORD With Physicians?

Cardiovascular outcomes data comparing fenofibrate and simvastatin versus just the statin could have implications for Abbott's cholesterol franchise.

More from Archive

More from Pink Sheet